International chronic ocular graft-vs-host-disease (GVHD) consensus group: Proposed diagnostic criteria for chronic GVHD (Part I)

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Ogawa, Yoko ^a   Kim, Stella K ^b   Dana, Reza ^c   Clayton, Janine ^d   Jain, Sandeep ^e   Rosenblatt, Mark I ^f   Perez, Victor L ^g   Shikari, Hasanain ^c   Riemens, Anjo ^h   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHRONIC DISEASE; CONSENSUS; EYE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; CHRONIC DISEASE; CONSENSUS; EYE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; YOUNG ADULT;

EID: 84890072447     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03419     Document Type: Article

References (49)

1. Shulman, H. M. et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69, 204-217 (1980). (Pubitemid 10036817)
2. Jabs, D. A. et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 107, 1343-1348 (1989). (Pubitemid 19229080)
3. Ogawa, Y. et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 83, 1125-1130 (1999). (Pubitemid 29469114)
4. Balaram, M. & Dana, M. R. Phacoemulsification in patients after allogeneic bone marrow transplantation. Ophthalmology 108, 1682-1687 (2001). (Pubitemid 32808350)
5. Couriel, D. R. et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 107, 3074-3080 (2006).
6. Kim, S. K. Update on ocular graft versus host disease. Curr Opin Ophthalmol 17, 344-348 (2006). (Pubitemid 44215042)
7. Lew, J. & Smith, J. A. Mucosal graft-vs-host disease. Oral Dis 13, 519-529 (2007). (Pubitemid 47610631)
8. Riemens, A., te Boome, L., Imhof, S., Kuball, J. & Rothova, A. Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol 21, 485-494 (2010).
9. Townley, J. R., Dana, R. & Jacobs, D. S. Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment. Semin Ophthalmol 26, 251-260 (2011).
10. Jacobs, R. et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 47, 1470-1473 (2012).
11. Hessen, M. & Akpek, E. K. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12, 540-547 (2012).
12. Shikari, H., Antin, J. H. & Dana, R. Ocular Graft-versus-Host Disease: A Review. Surv Ophthalmol (2013).
13. The definition and classification of dry eye disease: report of the Definition and Classification Subcommitteeofthe International Dry Eye WorkShop (2007). Ocul Surf 5, 75-92 (2007).
14. Ferrara, J. L., Levine, J. E., Reddy, P. & Holler, E. Graft-versus-host disease. Lancet 373, 1550-1561 (2009).
15. Filipovich, A. H. et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11, 945-956 (2005). (Pubitemid 41754712)
16. Dietrich-Ntoukas, T. et al. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea 31, 299-310 (2012).
17. Dignan, F. L. et al. Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol 158, 62-78 (2012).
18. Westeneng, A. C. et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 29, 758-763 (2010).
19. Ogawa, Y., Shimmura, S., Dogru, M. & Tsubota, K. Immune processes and pathogenic fibrosis in ocular chronic graft-versus-host disease and clinical manifestations after allogeneic hematopoietic stem cell transplantation. Cornea 29, S68-S77 (2010).
20. Riemens, A., Stoyanova, E., Rothova, A. & Kuiper, J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis 18, 797-802 (2012).
21. Inamoto, Y. et al. Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology 119, 487-493 (2012).
22. Wang, Y. et al. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant (2009).
23. Mencucci, R. et al. Ophthalmological aspects in allogenic bone marrow transplantation: Sjogren-like syndrome in graft-versus-host disease. Eur J Ophthalmol 7, 13-18 (1997). (Pubitemid 27140435)
24. Tichelli, A. Late ocular complications after bone marrow transplantation. Nouv Rev Fr Hematol 36 Suppl 1, S79-82 (1994).
25. Jack, M. K., Jack, G. M., Sale, G. E., Shulman, H. M. & Sullivan, K. M. Ocular manifestations of graft-v-host disease. Arch Ophthalmol 101, 1080-1084 (1983). (Pubitemid 13067503)
26. Jabs, D. A. et al. The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol 101, 585-590 (1983). (Pubitemid 13116468)
27. Hirst, L. W., Jabs, D. A., Tutschka, P. J., Green, W. R. & Santos, G. W. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 101, 580-584 (1983). (Pubitemid 13116467)
28. Franklin, R. M. et al. Ocular manifestations of graft-vs-host disease. Ophthalmology 90, 4-13 (1983). (Pubitemid 13175772)
29. Greinix, H. T. et al. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant 17, 167-175 (2011).
30. Kamoi, M. et al. Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation. Eye (Lond) 25, 860-865 (2011).
31. Takahashi, S. et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 109, 1322-1330 (2007). (Pubitemid 46220686)
32. Uchino, M. et al. Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation. Br J Ophthalmol 96, 34-37 (2012).
33. Rojas, B. et al. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res 81, 313-325 (2005). (Pubitemid 41208166)
34. Auw-Haedrich, C. et al. Histological and immunohistochemical characterisation of conjunctival graft vs host disease following haematopoietic stem cell transplantation. Graefes Arch Clin Exp Ophthalmol 245, 1001-1007 (2007). (Pubitemid 46979539)
35. Ogawa, Y. et al. Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. Am J Pathol 175, 2372-2381 (2009).
36. Robinson, M. R. et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 33, 1031-1035 (2004). (Pubitemid 38744790)
37. Tatematsu, Y. et al. Mucosal microvilli in dry eye patients with chronic GVHD. Bone Marrow Transplant 47, 416-425 (2012).
38. Hanada, R. & Ueoka, Y. Obstruction of nasolacrimal ducts closely related to graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 4, 125-126 (1989). (Pubitemid 19064920)
39. Ogawa, Y. et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 42, 111-119 (2001). (Pubitemid 32059417)
40. Kamoi, M. et al. Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res 32, 837-842 (2007). (Pubitemid 350034782)
41. Ban, Y. et al. Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 17, 2533-2543 (2011).
42. Espana, E. M., Shah, S., Santhiago, M. R. & Singh, A. D. Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol (2013).
43. Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D. & Reis, B. L. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 118, 615-621 (2000). (Pubitemid 30327337)
44. Miller, K. L. et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 128, 94-101 (2010).
45. Sullivan, B. D. et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 51, 6125-6130 (2010).
46. Bron, A. J., Evans, V. E. & Smith, J. A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22, 640-650 (2003). (Pubitemid 37175145)
47. Efron, N. Grading scales for contact lens complications. Ophthalmic Physiol Opt 18, 182-186 (1998). (Pubitemid 28132673)
48. Dogru, M. et al. Changing trends in the definition and diagnosis of dry eyes. Am J Ophthalmol 140, 507-508 (2005).
49. Wang, Y. et al. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant 45, 1077-1083 (2010).